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INTRODUCTION

The potential for hair cell regeneration therapies is currently gaining public interest and
awareness. In a recent study conducted by Ali, Williams, Jackson, and Pau (2012), a questionnaire was distributed to members of the British Association of Otorhinolaryngologists, and 11%
of responders reported that patients had specifically asked them about hair cell regeneration and
stem cell therapies. Audiologists should know that the patients most likely to benefit from the
advancement of hair cell regeneration research are those that have damage limited to the level of
the hair cell. Deterioration of cochlear cells and structures other than hair cells, as seen in animal
models experiencing noise-induced (Wang, Hirose, and Liberman, 2002) and age-related
(Ohlemiller, Dahl, and Gagnon, 2010) hearing loss, would not be targeted for repair with hair
cell regeneration therapies. In the present study, an additional limitation of the hair cell
replacement mechanism is uncovered using five day post-fertilization zebrafish treated with
cisplatin.

LITERATURE REVIEW

I. Cisplatin Toxicity
Cis-platinum (II) diamine dichloride, commonly referred to as cisplatin, is a chemotherapeutic agent that was first introduced in the 1970s to treat ovarian, testicular, cervical, bladder,
lung, and head and neck tumors (reviewed in Gratton and Smyth, 2004; Yorgason, Fayad, and
Kalinec, 2006; Rybak, 2007; Rybak, Mukherjea, Jajoo, and Ramkumar, 2009). The mechanism
by which cisplatin appears to treat soft tissue cancers is through the creation of intrastrand crosslinks in the deoxyribonucleic acid (DNA) of mitotically-active cells. When the nuclear DNA of
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dividing cells is adducted in this fashion, DNA replication is inhibited and apoptosis or
programmed cell death is initiated if these cross-links are not repaired (e.g., by a nucleotide
excision repair system). Similar to other platinum-based chemotherapy agents, cisplatin has
several undesirable side effects including ototoxicity, nephrotoxicity, neurotoxicity, emesis, and
nausea. Animal models have shown that cisplatin also damages inner ear hair cells, supporting
cells, spiral ganglion cells, the spiral ligament, and the stria vascularis, specifically. Despite these
known side effects, physicians continue to prescribe cisplatin to cancer patients because of its
unparalleled effectiveness against soft tissue cancers and because neoplasms have a low
likelihood of developing resistance to cisplatin compared to other chemotherapy drugs.

II. Hair Cell Function, Death, and Regeneration
Hair cells are mechanosensory receptor cells found within the hearing, vestibular, and
lateral line organs of vertebrate species. When the stereocilia along the apical surfaces of hair
cells are displaced, neural processes surrounding the hair cells generate electrical impulses that
are transmitted to the brain (reviewed in Hudspeth, 1997). These neural inputs are used to inform
the organism that sound waves, head movements, changes in body orientation, or surrounding
water currents have been detected (reviewed in Matsui & Ryals, 2005 and Salvi, 2008).
Hair cell loss contributing to hearing and/or balance disturbances can result from extreme
environmental stress. Damaging amounts of noise, aminoglycosides, and cisplatin have all been
shown to increase the level of reactive oxygen species (ROS) present inside hair cells and can
initiate apoptosis when an unidentified threshold of ROS has been reached (Ou, Raible, and
Rubel, 2007; reviewed in Gratton and Smyth, 2004; Yorgason et al., 2006; Rybak, 2007; Stone
and Contanche, 2007; Rybak et al., 2009). Since auditory hair cells are rarely produced after
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embryogenesis in mammalian species (reviewed in Oesterle and Stone, 2008 and Warchol,
2011), the result of cochlear hair cell death is permanent sensory hearing loss.
Unlike their mammalian counterparts, birds, reptiles, amphibians, and fish all maintain
the capacity to regenerate cochlear hair cells beyond the late embryonic period. Regeneration of
hair cells following exposure to damaging levels of noise and ototoxic drugs has also been noted
in all four animal classes (reviewed in Oesterle and Stone, 2008; Warchol, 2011). Why hair cell
regeneration persists in nonmammals but not mammals is unknown, but one theory proposes that
mammals made an evolutionary tradeoff at some point in their history – the ability to regenerate
cochlear hair cells for the complex hearing organ needed to achieve high frequency sensitivity
(Warchol, 2011). Regardless of whether or not this theory is true, one of the main challenges to
treating hearing loss in humans will undoubtedly be the need to regenerate cochlear hair cells
without interfering with the intricate structure of the mammalian organ of Corti.
Within the sensory epithelia of the auditory, vestibular, and lateral line systems, both
sensory hair cells and nonsensory supporting cells are present. Sensory hair cell somata contact
the luminal surface of the epithelium, and supporting cell somata are interspaced between them.
When hair cell regeneration is not taking place, nonsensory supporting cells are in a state of
quiescence. Their somata contact the luminal and basal surfaces of the epithelium, and their
nuclei are located more towards the basal side. Compared to sensory hair cells in avian and fish
species, nonsensory supporting cells are morphologically simple, exhibiting a noncomplex cytoskeleton and few organelles. As hair cell death occurs, it is these seemingly undifferentiated
supporting cells that replenish the lost population of hair cells through either direct transdifferentiation or mitotic proliferation (reviewed in Stone and Cotanche, 2007; Oesterle and Stone, 2008;
and Brignull, Raible, and Stone, 2009).
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During direct transdifferentiation, dying hair cells are replaced by adjacent supporting
cells that have undergone phenotypic conversion and transformed into new hair cells. This
mechanism, at least in theory, is capable of replacing lost hair cells so long as the endogenous
population of supporting cells is not depleted. Surprisingly, what appears to limit the utility of
this mechanism has less to do with the number of supporting cells remaining and more to do with
the number of essential functions assigned to supporting cells. For instance, not only do supporting cells serve as precursor cells during direct transdifferentiation but they also contribute to the
endocochlear potential through potassium (re)cycling and provide structural support to hair cells,
spiral ganglion terminals, and the sensory epithelium as a whole. If direct transdifferentiation
was the only method by which nonmammalian species were able to regenerate lost hair cells,
then the sensory epithelium would effectively collapse and deteriorate whenever it experienced a
massive hair cell lesion. For this reason, direct transdifferentiation appears to have evolved as an
"early response" or a "quick fix" for replacing a few lost hair cells.
When extensive hair cell damage occurs, supporting cells leave growth-arrest, reenter the
cell cycle, and undergo mitosis. The two cells resulting from the division may then differentiate
into a symmetrical pair of two new hair cells, a symmetrical pair of two new supporting cells, or
an asymmetrical pair comprised of one new hair cell and one new supporting cell. Current thinking suggests that these three outcomes are likely balanced and highly regulated so as to ensure
that the correct number of hair cells and supporting cells are regenerated without jeopardizing the
important role supporting cells play in maintaining inner ear homeostasis. At present, it is
unclear whether three different populations of supporting cells exist (i.e, a population devoted to
direct transdifferentiation, a population devoted to mitotic proliferation, and a population
devoted to standard supporting cell functions) or if all supporting cells possess the potential to
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perform all three functions based on local cell signaling. Since supporting cells serve as the
replacement stock for dying hair cells (Williams and Holder, 2000) regardless of the hair cell
replacement mechanism used, supporting cells can be viewed as a type of progenitor cell if not a
true stem cell.

III. The Benefits of Using a Zebrafish Model
Neuromasts are mechanosensory organs found in fish and amphibian species. They contain a cluster of centrally-located hair cells surrounded by intervening supporting cells. When
neuromasts are organized into species-specific patterns on the bodies of fish, the result is the
lateral line system (Ledent, 2002; Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudière, 2004; Chiu, Cunningham, Raible, Rubel, and Ou, 2008). The lateral line system is used to
sense water disturbances in a fish’s immediate environment, and it plays an important role when
fish are swimming in schools, socially interacting with one another, and localizing predators and
prey (Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudière, 2004).
The embryonic posterior lateral line of zebrafish (Danio rerio) is comprised of between
seven and eight neuromasts that extend from the head of the fish to the tip of the tail (Ledent,
2002; Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudière, 2004). As described in
Ledent (2002), development of the embryonic posterior lateral line is complete by three days
post-fertilization (dpf); however, the lateral line continues to develop as a fish matures. Starting
between three and four dpf, new neuromasts appear interspersed between the previously developed neuromasts and posterior lateral line neuromasts begin to migrate ventrally. The three most
posterior neuromasts, in particular, rearrange themselves with the penultimate neuromast moving
to a more ventral position than the surrounding two. This movement seemingly appears in anti-
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cipation of the developing bend in a fish’s tail. Ledent stresses that postembryonic growth of the
zebrafish lateral line is highly dependent upon a fish’ size rather than its age. When a fish
reaches approximately 10-12 millimeters in length, its posterior lateral line neuromasts begin to
contribute to the formation of stitches where new neuromasts appear to bud off and travel away
from existing neuromasts in a dorsoventral fashion.
Despite the level of postembryonic growth seen in the zebrafish lateral line, it is a
practical model for studying hair cell death and regeneration for several reasons (Chiu et al.,
2008). First, lateral line hair cells are structurally and functionally comparable to those found
within the mammalian inner ear despite obvious differences in cellular organization (i.e.,
neuromasts vs. the organ of Corti). Second, like inner ear hair cells, lateral line hair cells are
vulnerable to ototoxic drugs such as aminoglycosides and cisplatin. Unlike cochlear hair cells,
however, neuromast hair cells do no require invasive techniques to be accessed. They are
superficially located on the body surfaces of fish. An additional benefit to working with zebrafish larvae is that they are optically transparent and therefore amenable to immunoflourescent
dyes taken up by hair cells (Quigley and Parichy, 2002; Dambly-Chaudière et al., 2003). Finally,
zebrafish larvae are an ideal laboratory specimen because they exhibit rapid development and
high fecundity when adulthood is reached (Quigley and Parichy, 2002; Chiu et al., 2008). By
five days old, zebrafish larvae have developed an average of 10±2.7 hair cells per neuromast
(Genualdi, 2012), and this number doubles by ten days of age (Williams and Holder, 2000).

IV. Previous Research on Hair Cell Regeneration within the Zebrafish Lateral Line
Several lines of research suggest that hair cell replacement within the zebrafish lateral
line is a highly regulated process sustained by a population of proliferating supporting cells that
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differentiate into hair cells. López-Schier and Hudspeth (2006) were the first to characterize hair
cell regeneration patterns in ET4 transgenic zebrafish following treatment with neomycin.
According to the authors, transgenic zebrafish of the ET4 line are identical to wild-type zebrafish
in all ways except for the expression of a green florescent protein in lateral line hair cells and in
progenitor cells shortly before they differentiate into hair cells. Using live imaging techniques,
López-Schier and Hudspeth monitored hair cell regeneration in the neuromasts of fourteen ET4
trangenic zebrafish and found that, prior to their final mitosis, progenitor cells appeared in
positions perpendicular to the neuromasts’ axes of hair cell polarization. Progenitor cells were
thus seen in positions anterior to and posterior to neuromast hair cells when hair cells were
regenerating along a dorsoventral axis or vice versa. Given this finding, the authors concluded
that hair cell orientation in zebrafish larvae is partially based upon the positioning of progenitor
cells which are, in turn, situated in the neuromast depending upon the axis of hair cell planar
polarity. Production of the Vangl2 protein was then found to govern kinocilia and stereocilia
arrangement atop regenerating hair cells.
Although López-Schier and Hudspeth did not directly investigate direct transdifferentiation versus mitotic proliferation methods of hair cell replacement in the zebrafish lateral line,
they did hypothesize that direct transdifferentiation would be unlikely to dominate over mitotic
proliferation for two reasons. First, the time course for hair cell replacement following treatment
with neomycin sulfate did not seem accelerated or extensive enough to suggest that supporting
cells were transdifferentiating. Second, a single neuromast contains roughly 30 supporting cells.
If direct transdifferentiation had been occurring to a substantial degree, this small population of
cells would have been depleted or significantly reduced in the two day’s time it took to replace
the ablated hair cells.
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Additional experiments by Mackenzie and Raible (2012) have also suggested that mitotic
regeneration is the primary mechanism by which lateral line hair cell replacement is performed
in zebrafish. Five dpf zebrafish larvae were treated with aminoglycosides or copper (II) sulphate
at concentration levels known to result in near complete recovery of lateral line hair cells. After
treatment with these ototoxic compounds, larvae were incubated for two days in flubendazole, a
drug that has limited toxicity to hair cells but has been shown to inhibit microtubule assemblage
during chromosome segregation. After larval incubation in flubendazole, Mackenzie and Raible
noted a significant reduction in hair cell regeneration and a significant increase in phosphorylated histone H3 (PH3) expression in progenitor cells. Since PH3 is expressed in mitotic cells
transitioning from the gap 2 phase to metaphase (a stage during mitosis), the authors concluded
that flubendazole appears to hinder hair cell regeneration by arresting cellular division—not by
blocking direct transdifferentiation. If flubendazole had prevented precursor cells from transdifferentiating, the authors believe they would have seen an increase in precursor cell numbers
and not progenitor cell numbers. For this reason, the authors conclude that mitotic proliferation is
the dominant mechanism responsible for lateral line hair cell replacement after ototoxic injury.
Presently, two distinct supporting cell populations have been proposed to contribute to
the regeneration of lateral line hair cells in zebrafish – an internal supporting cell population
located in the center of zebrafish neuromasts and two to three layers of peripheral (or mantle)
supporting cells lying along the periphery of each neuromast. During an experiment conducted
by Ma, Rubel, and Raible (2008), five dpf zebrafish larvae were treated with neomycin and then
incubated in the Notch inhibitor DAPT. Following neomycin treatment and incubation in
DAPT, internal supporting cell proliferation was found to significantly increase and peripheral
supporting cell proliferation was found to decrease inside lateral line neuromasts. Excess
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regeneration of hair cells was then noted shortly thereafter. Based on these results, Ma et al.
suggested that internal supporting cells undergo mitotic division and differentiation in order to
replace lost hair cells and peripheral supporting cells only divide when the structural integrity of
a neuromast is compromised or additional growth is required.
Studies have shown that hair cell replacement within the zebrafish lateral line occurs as
part of a fish’s natural development and in response to damaging insults such as tail amputation
and ototoxic exposure (Williams and Holder, 2000; see Stone and Cotanche, 2007, for a review).
Following treatment with aminoglycosides and limited amounts of copper (II) sulphate, for instance, near complete restoration of lateral line hair cells has been observed within 24-72 hours
of recovery (Harris et al., 2003; Ma et al., 2008; Mackenzie and Raible, 2012). Only a handful of
studies, however, have investigated the effects of cisplatin on zebrafish lateral line hair cells.

V. Justification for the Present Study
Understanding the mechanisms underlying the initiation and maintenance of hair cell
regeneration in animal models is important as the knowledge gained may contribute to the
development of human hair cell replacement procedures via gene therapies, stem cell therapies,
or possibly drug therapies that induce endogenous supporting cells to transdifferentiate into hair
cells (Mizutari et al., 2013; reviewed in Brigande and Heller, 2009; Groves, 2010; Warchol,
2011). While many additional factors need to be considered before one can readily assess the
clinical utility of hair cell regeneration in humans, Matsui and Ryals (2005) and Ryals (2009)
hypothesize that the renewal of a few fully functional and innervated hair cells within the
cochlea would likely result in improved hearing aid benefit even if the complete restoration of
normal hearing is not possible. In addition, patients suffering from the effects of vestibulotoxic
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drugs (e.g., gentamicin) may also be better able to compensate if hair cell regeneration in the
vestibular organs can be induced.
Given that cisplatin is toxic to hair cells, proliferating cells, and supporting cells, it seems
plausible that cisplatin would severely limit or completely shutdown the regenerative process in
non-mammalian species. Interestingly, Slattery and Warchol (2010) came to that conclusion in a
study examining the capacity of chick hair cells to regenerate in the presence of cisplatin. In their
study, cochlear and utricular organotypic cultures taken from 7-14 day post-hatch chicks were
incubated in 0.2 to 20.0 micromolar (μM) cisplatin for 24 hours and permitted to recover for up
to seven days. After cisplatin administration, the authors noted a dose-dependent increase in the
amount of hair cell death and a dose-dependent decrease in the amount of cell proliferation
observed. In addition, cisplatin-treated cultures did not show an increase in hair cell numbers
compared to controls even after being incubated in the Notch inhibitor DAPT. Given these findings, the authors concluded that cisplatin appears to have a toxic effect on both hair cells and
supporting cells in the avian inner ear for at least seven days following cisplatin injury.
To determine whether or not comparable effects were observed in the zebrafish lateral
line, Genualdi (2012) treated five dpf zebrafish larvae with 1000 μM cisplatin for four hours and
then allowed them to recover for up to 10 days. After the cisplatin exposure, neuromast hair cell
counts were found to decrease to approximately 10-20% of those seen in undamaged controls
and they did not fully recover. Surviving and regenerated hair cell numbers only reached 60% of
those seen in the undamaged controls 10 days-post injury. When incubated in 50 μM DAPT,
however, a twofold increase in the number of regenerated hair cells was noted as early as three
days post-injury. Nevertheless, the resulting hair cell numbers were still so low (0.08 ± 0.20 hair
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cells per neuromast) that the addition of DAPT following cisplatin treatment did not appear to
enhance the regenerative response in any meaningful way.
Mackenzie and Raible (2012) obtained similar findings to Genualdi (2012) using a much
lower dose of cisplatin (50 μM). Following treatment with cisplatin for 24 hours, 5 dpf zebrafish
larvae exhibited incomplete hair cell replacement at 96 hours post-injury with the experimental
group displaying approximately 25% fewer hair cells than the control group. In addition, the
regenerative response following cisplatin was noted to be delayed compared to that following
treatment with various aminoglycosides.
Collectively, these findings suggest that either a.) zebrafish internal and/or peripheral
supporting cells are less susceptible to cisplatin than are chick inner ear progenitors (Genualdi,
2012) or b.) lateral line supporting cells have some sort of robust DNA repair mechanism that is
not found in the chick inner ear (Mackenzie and Raible, 2012). In discussing the persistence of
hair cell regeneration in the zebrafish lateral line, however, it is important to keep in mind that
hair cell replacement is both delayed and less robust following treatment with cisplatin than
following treatment with aminoglycosides or copper sulphate. At present, only a few studies
have investigated supporting cell proliferation patterns within the zebrafish lateral line after toxic
damage. The studies that have focused primarily on the response initiated by aminoglycosides.
No studies have assessed the resulting proliferation patterns resulting from cisplatin exposure.
For this reason, the goal of the present study was to characterize the time course and patterning
of nonsensory supporting cell proliferation within the zebrafish lateral line post-cisplatin treatment.
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RESEARCH QUESTIONS AND HYPOTHESES

Since antineoplastic agents are known to terminate mitotically-active cells through the
initiation of apoptosis, the following Capstone Project sought to characterize the effects of
cisplatin on proliferating supporting cells within the zebrafish lateral line. Specifically, we
examined whether cisplatin was toxic to dividing inner and peripheral supporting cells as well as
lateral line hair cells and, if so, what consequences this toxicity appeared to have on their proliferation patterns compared to untreated controls. The null and alternative hypotheses for this
project were as follows:
•

H 0 : Average supporting cell counts obtained for control versus experimental neuromasts
would not be significantly different for any recovery period following treatment with
cisplatin.

•

H 1 : Average supporting cell counts obtained for control versus experimental neuromasts
would be significantly different for one or more recovery periods following treatment
with cisplatin.

MATERIALS AND METHODS

I. Zebrafish Husbandry
Zebrafish embryos were obtained from AB wild type pairings of adult fish housed in the
fish facility at Washington University in St. Louis. The embryos were then maintained in a tissue
culture incubator at 28.5ºC in embryo medium (EM: 1 mM MgSO 4 , 0.15 mM KH 2 PO 4 , 0.04 mM
Na 2 HPO 4 , 1 mM CaCl 2 , 0.5 mM KCl, 15 mM NaCl, and 0.7 mM NaHCO 3 , pH 7.2). At 2-3 days
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post-fertilization (dpf), embryogensis had ended and the specimens were considered larvae
(Ledent, 2002; Dambly-Chaudière et al., 2003). According to the guidelines set forth by the
Institutional Animal Research Committee at Washington University in St. Louis, zebrafish larvae
are not viewed as vertebrate animals and do not require approval for experimentation. Zebrafish
larvae were then housed in 85 millimeter (mm) Petri dishes and fed live rotifers once per day.
Prior to initiation of the experiments, the Petri dishes were tapped lightly to ensure that the fish
had a normal startle response.

II. Cisplatin Treatment
Five dpf zebrafish larvae (N = 85) were incubated in a 1000 μM solution of cisplatin
(Sigma Aldrich) for four hours at 28.5ºC. The chosen treatment protocol was selected as
previous work by Ou et al. (2007) and Genualdi (2012) indicated that it was appropriate for killing the majority of lateral line hair cells. Age-matched controls (N = 51) were then incubated in
cisplatin-free EM under the same conditions.

III. Cell Proliferation Assay
In order to characterize supporting cell proliferation at different points in time following
cisplatin treatment (or lack thereof), zebrafish larvae were rinsed in fresh EM three times over
thirty minutes and then incubated in a 5 mM solution of bromodeoxyuridine (BrdU) in EM. BrdU
is a nucleotide analog that is incorporated into the cellular DNA of a specimen’s cells during the
S-phase prior to mitosis. As such, it can be used to label cells preparing to undergo mitotic
division. For the present experiment, two labeling paradigms were employed (Figure 1).
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A. BrdU Pulse-Fix Protocol
A BrdU pulse-fix protocol was used to identify all progenitor cells undergoing division
during the final 24 hours prior to fixation. For the pulse-fix paradigm, both control and experimental fish were permitted to recover for 24, 48, 72, or 96 hours in fresh EM following cisplatin
or mock treatment. During the final 24-hour survival period, fish were then incubated in 5 mM
BrdU in EM prior to fixation.
Approximately twenty fish were randomly assigned to each of the eight conditions in the
BrdU pulse-fix paradigm (cisplatin treatment x four survival periods + mock treatment x four
survival periods = eight conditions); however, some specimens were lost during cisplatin treatment or immunoprocessing. No fewer than eight and no more than nineteen fish contributed to
the data set for each condition.

B. BrdU Pulse-Chase Protocol
A BrdU pulse-chase protocol was used to identify all progenitor daughter cells that managed to survive the cisplatin treatment for up to three days. Since BrdU is incorporated into the
cellular DNA of mitotically-active cells, all progeny arising from initial progenitor divisions contain the BrdU analog and can be tracked. For the pulse-chase paradigm, experimental fish were
treated with cisplatin for four hours; permitted to recover for 12 hours; incubated in 5 mM BrdU
for four hours; and then permitted to recover for an additional 0, 24, 48, or 72 hours in fresh EM.
This protocol was selected because proliferation levels were found to be at their highest approximately 15 hours post-neomycin injury (Ma et al., 2008).
Approximately 20 fish were randomly assigned to each of the four conditions in the BrdU
pulse-chase paradigm (cisplatin treatment x four survival periods = four conditions). Ultimately,

14

Street
no fewer than 10 and no more than 11 fish contributed to the data set for each condition. Additional fish were processed for each of the four conditions but could not be included in the final
data sets due to time constraints.

Figure 1. Bar graphs illustrating the main differences between the two experimental protocols. A. For the
BrdU Pulse-Fix protocol, animals were treated with cisplatin (CPPD) for four hours, permitted to recover between
24-96 hours, and incubated in BrdU during their final 24 hour survival period. B. For the BrdU pulse-chase protocol,
animals were treated with CPPD for four hours, allowed to recover for 12 hours, incubated in BrdU for four hours,
and then allowed to recover for an additional 0-72 hours.

IV. Fixation and Immunohistochemistry Procedures
All fish, regardless of the BrdU-labeling protocol employed, were sacrificed with an
overdose of 0.02% Tricaine and fixed in 4% paraformaldehyde in phosphate buffered saline
(PBS) overnight. Following fixation, zebrafish larvae were rinsed for five minutes five times in
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PBS. The specimens were then incubated in 2 normal (N) hydrochloric acid (H-Cl) for 45 minutes to make their fixed tissues more permeable to antibody application. After incubation in 2 N
H-Cl, the specimens were rinsed for five minutes three times in PBS and then transferred into a
blocking solution containing 5% normal horse serum and 95% PBS with 1% Triton X-100 detergent and 1% dimethyl sulfoxide (DMSO) to further increase tissue permeability for two hours.
As is the case with all studies employing immunohistochemistry techniques, specimens were
blocked prior to application of the primary antibodies in order to diminish nonspecific binding of
the primary antibodies and to improve the resulting signal-to-noise ratio. When specimens are
blocked in this fashion, the likelihood that the primary antibody will bind to the wrong antigen
epitopes or protein locations is reduced (Jantzie, Tanay, and Todd, 2007).
After each specimen was blocked, the fish were incubated in PBS containing mouse antiBrdU primary antibodies (1:50) overnight at room temperature along with 1% Triton X-100 and
5% normal horse serum. Anti-BrdU primary antibodies bind to BrdU antigens incorporated into
a specimen’s DNA. Primary antibodies then serve as new epitopes for secondary antibodies conjugated with fluorescent molecules. One benefit to using an indirect immunohistochemistry
procedure such as this is that multiple fluorescent secondary antibodies can bind to a single
primary antibody and, thus, amplify the fluorescent signal observed (Jantzie et al., 2007; Carter
and Shieh, 2010a). Additional Triton X-100 and normal horse serum were then used for the same
reasons discussed previously.
Following incubation in the primary antibody, the fish were rinsed for five minutes five
times in PBS and incubated for 2 hours at room temperature in PBS containing Alexa 488-conjugated goat anti-mouse (1:500) secondary antibodies and 4',6-diamidino-2-phenylindole (DAPI
1:500). Anti-mouse Alexa 488 antibodies bind to mouse anti-BrdU antibodies and cause all mito-
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tically-active nuclei to fluoresce green. The counter stain DAPI binds to the A-T regions in cellular DNA and stains all cell nuclei blue. By staining all cell nuclei along the surface of the fish
blue, the investigator was better able to identify cellular “landmarks” and, thus, more readily
recognize where cell proliferation was taking place within the lateral line. Upon completion of
the immunofluorescent antibody staining protocol, the zebrafish larvae were mounted on standard microscope slides and coverslipped. Care was taken to ensure that the tail surfaces of the
specimens were lying flat and facing upwards. Positioning the fish in this manner was important
as it provided a clear shot of the lateral line neuromasts during confocal imaging.

V. Imaging
To assess the degree of supporting cell proliferation following cisplatin treatment, a Carl
Zeiss LSM 700 Confocal Microscope with a 20x objective lens was used to image the three most
posterior neuromasts of each specimen. Confocal microscopy was selected for this purpose as it
is the gold standard for imaging thick sections and small intact organisms such as zebrafish
(Carter and Shieh, 2010b). Images were then captured using Zeiss proprietary software (ZEN)
with the averaging parameter set to two and the acquisition speed set to seven. The gain of the
microscope was set to the maximum value permissible before pixel saturation occurred (i.e.,
between 550-800 gain). All images were subsequently analyzed using Volocity.
As described in Carter and Shieh (2010b), a confocal microscope works by passing a
laser through a fluorescently stained specimen at a specified depth. The laser illuminates the
selected plane of interest, and emitted light from the specimen is received by a detector positioned confocal to the laser. A confocal microscope essentially scans very thin sections of a
specimen and produces a stack of images referred to as a Z-stack. Z-stacks are then used to
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construct 2D or 3D images of the specimen on a computer. In the present experiment, the first
image in a Z-stack was set to a depth where the specimen’s neuromasts first became visible
under the microscope. The last image in the Z-stack was then set to a depth inside the specimen
where the neuromasts were no longer visible. The last image in the Z-stack captured an outline
of the specimen's tail but did not represent the reverse side of the fish. Care was taken to ensure
that the reverse side of the fish was not imaged as any proliferation occurring on that side would
have contaminated the resulting 2D image.

VI. Data Quantification
Counts of mitotically-active cells were performed for the three most posterior neuromasts
of each fish using Volocity and the XYZ image mode. Volocity’s XYZ image mode was selected
over the Extended Focus image mode as rotating through each image of the Z-stack made it
easier to disambiguate cases where a lot of cellular proliferation was taking place. Both single
and dividing BrdU+ cell counts were made (Figure 2) as well as BrdU+ internal and peripheral
supporting cells counts. Internal supporting cell counts were performed with relative ease as they
were fairly straight forward to identify within the body of a neuromast. Peripheral supporting cell
counts, however, proved to be more difficult as skin lesions about the neuromast appeared to
arise from the cisplatin exposure. To help maintain consistency across neuromasts when
counting BrdU+ internal and peripheral supporting cells, the following criteria were developed:
1. BrdU+ cells were counted as internal supporting cells when they a.) exhibited small
round or cylindrical nuclei and b.) were located centrally within the neuromast.
2. BrdU+ cells were counted as peripheral supporting cells when they a.) exhibited larger
cylindrical nuclei and b.) were situated in either the outermost layer of neuromast cells or
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the one to two cell layers immediately beyond the periphery of the neuromast. Large
nebulous BrdU+ cells were never included in the peripheral cell counts unless they
appeared by other BrdU+ peripheral cells in a clear semicircular pattern about the
neuromast.

Figure 2. Cell division inside a zebrafish neuromast. Cells entering S-phase are labeled with BrdU, and
surrounding cell nuclei are counterstained with DAPI. The long arrow with a pointed tail identifies a cell undergoing
division at the time of fixation. The short arrow points to a single cell that has entered S-phase. Scale bar = 10
micrometers (μm).

Following peripheral and internal supporting cell counts, each neuromast was divided
into four quadrants (anterior, ventral, posterior, and dorsal) to assess directional proliferation
patterns. Given that existing neuromasts contribute to the formation of dorsolateral stitches
(Ledent, 2002), the present study assessed proliferation patterns along the anteroposterior and
dorsoventral axes. The four neuromast quadrants were created in Volocity using the line tool and
the Alexa channel turned off. The Alexa channel was turned off so as to reduce bias when
drawing the quadrant lines. The number of proliferating cells present in each quadrant was then
assessed with the Alexa channel turned back on. When a BrdU+ cell fell into more than one
quadrant, it was assigned to the quadrant that housed the majority of its nucleus. This procedure
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is illustrated in Figure 3 below. While not initially intended for this purpose, the quadrant
supporting cell counts provided a nice check for consistency as they were performed separately
from the type supporting cell counts. If the investigator was consistent in making the BrdU+
supporting cell counts, both the quadrant and the type supporting cell counts should have
been the same. In cases where the two counts were not equivalent, the investigator returned to
the particular neuromast in question and performed the two counts again. Rarely did the two
counts differ by more than one or two cells.
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Figure 3. Creating quadrants for directional proliferation counts. In panels A and B, cells entering S-phase are
labeled with BrdU and surrounding cell nuclei are counterstained with DAPI. A. Intersecting lines are drawn over
the three most posterior neuromasts of each specimen using Volocity’s line tool and the BrdU channel turned off. B.
Both channels (DAPI + BrdU) are then turned on to make cell counts for the individual quadrants. The numbers in
the figures represent the total length of each pair of intersecting lines. Scale bars = 10 μm.
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VII. Data Analysis and Statistical Procedures
Descriptive and inferential statistical analyses were conducted using Microsoft Excel. All
resulting data are presented as means ± one standard deviation. Where appropriate, two-tailed ttests and one way analyses of variance (ANOVAs) were performed to assess statistical differences amongst the control and experimental data after each assigned recovery period. Multiple
comparisons tests, such as Tukey’s test, could not be performed due to the statistical limitations
of Excel. Differences were considered statistically significant when p < 0.05. Upon completion
of data analysis, Excel was also used to generate representative graphs for the data. In all graphs,
errors bars represent standard deviations.

RESULTS

I. Results for the BrdU Pulse-Fix Experiment
The relative amount of cell proliferation occurring in the three most posterior neuromasts
of 5 dpf zebrafish larvae following treatment with 1000 μM cisplatin or cisplatin-free EM for
four hours was assessed at 24, 48, 72, and 96 hours post-treatment (Figure 4). All cells undergoing DNA replication during the final 24 hours of survival were labeled by incubating the fish
in 5 mM BrdU. Immediately following incubation in BrdU, the fish were anesthetized and fixed.
Figure 5 displays the mean number of peripheral and internal supporting cells that had incorporated BrdU at the four assessment points. Descriptive data for all figures presented in this paper
are provided in the supplemental tables located in the appendix.
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A. Moderate Levels of Proliferation Occur in Untreated Control Neuromasts
As was observed in Williams and Holder (2000) and Ma et al. (2008), control neuromasts
appeared to exhibit ongoing proliferation during the four survival periods. The reason for this
constant turnover of cells is unknown but it has likely developed out of necessity. Unlike auditory and vestibular hair cells, lateral line hair cells are directly exposed to damaging agents being
situated on the exterior surface of a fish’s body.

B. Proliferation is Transiently Upregulated in Cisplatin-Treated Neuromasts
Overall proliferation levels declined for both the control and experimental groups during
the first 24-96 hours after cisplatin administration. Cisplatin-treated neuromasts, however, displayed significantly more BrdU+ peripheral and internal supporting cells than did control neuromasts at the 48 and 72 hour assessment points (p < 0.05 or 0.005 for peripheral and internal
supporting cell counts, p < 0.0005 for total supporting cell counts). This suggests that, compared
to control animals, the number of cells entering S-phase is temporarily upregulated during the
48-72 period following cisplatin treatment. When experimental animals were assessed another 24
hours later, proliferation levels had returned to control levels.

C. Both Supporting Cell Subpopulations Contribute Equally to the Proliferative Response
BrdU+ internal supporting cell counts did not differ significantly from BrdU+ peripheral
supporting cell counts at any time point in any group save for one exception. Control neuromasts
displayed significantly more BrdU+ internal cells than peripheral cells at the 24 hour assessment
point (p < 0.05). These findings are in stark contrast to those reported by Ma et al. (2008).
Fifteen days after neomycin treatment, when the proliferative response had peaked, BrdU+
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internal supporting cell counts outnumbered BrdU+ peripheral supporting cell counts by a factor
of approximately 2:1. Interestingly, Williams and Holder (2000) and Harris et al. (2003) noted
the reverse trend following neomycin treatment although they did not provide exact counts for
the two populations of cells.

Figure 4. Supporting cell proliferation in the three most posterior neuromasts of zebrafish after treatment
and one to four days (1D-4D) of recovery. In panels A-H, cells entering S-phase are labeled with BrdU and
surrounding cell nuclei are counterstained with DAPI. A-D. Images depict representative neuromasts from control
(CTL) animals following mock treatment, a recovery period, and a 24 hour BrdU pulse immediately prior to fixation. The number of additional BrdU+ cells appearing in neuromasts after the first day of recovery declines rapidly.
E-H. Images depict representative neuromasts from cisplatin-treated (CDDP) animals following a recovery period
and a 24 hour BrdU pulse immediately prior to fixation. The number of additional BrdU+ cells appearing in neuromasts after the first day of recovery declines more gradually in the cisplatin-treated fish compared to controls. Long
arrows with pointed tails indicate sample peripheral supporting cells, and short arrows indicate sample internal
supporting cells. Scale bars = 10 micrometers (μm).
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Figure 5. Time course graph showing the mean number of internal and peripheral BrdU+ cells at each of the
24-96 hour assessment points for the control (CRL) and cisplatin-treated (CPPD) animals in the BrdU pulsefix experiment. Compared to controls, a transient but significant increase in the mean number of added BrdU+
internal and peripheral supporting cells is seen between 48 and 72 hours after cisplatin treatment in the experimental group. Mean BrdU+ internal supporting cell counts do not significantly differ from mean BrdU+ peripheral
supporting cell counts except for in the controls at the 24 hour assessment point. Error bars represent positive
standard deviations (N = 8-19 fish per condition, 3 neuromasts per fish). Asterisks with brackets denote significant
differences (p < 0.05 or 0.005) between the control and experimental groups. Solitary asterisks indicate a significant
difference (p < 0.05) between the mean internal and peripheral supporting cell counts.

D. Proliferation is Homogenously Distributed within Zebrafish Neuromasts
Previous research has indicated that developmental growth and supporting cell proliferation could occur along either a dorsoventral or anteroposterior axis (Ledent, 2002; López-Schier
and Hudspeth, 2006). For this reason, individual neuromasts were divided into four quadrants so
that proliferation patterns could be assessed along the two axes. As displayed in Figure 6, BrdU+
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cell counts for the dorsoventral axis were not significantly higher than BrdU+ cell counts for the

Mean Number of BrdU+ Cells per Neuromast

anteroposterior axis except for in the 24 hour control group (p < 0.05).

Figure 6. Time course graph showing the mean number of dorsoventral and anteroposterior BrdU+ cells per
neuromast at each of the 24-96 hour assessment points for the control (CRL) and cisplatin-treated (CPPD)
animals in the BrdU pulse-fix experiment. The mean number of additional cells entering S-phase along the dorsoventral axis is not significantly higher than the mean number of additional cells entering S-phase along the anteroposterior axis except for in the controls at the 24 hour assessment point. Error bars represent positive standard
deviations (N = 8-19 fish per condition, 3 neuromasts per fish). The solitary asterisk denotes a significant difference
(p < 0.05) between the mean dorsoventral and anteroposterior cell counts.

II. Results for the BrdU Pulse-Chase Experiment
Five dpf zebrafish larvae were treated with 1000 μM cisplatin for four hours and then
incubated in 5 mM BrdU for the same period of time 12 hours post-treatment. Prior to fixation,
fish were permitted to recover for 0, 24, 48, or 72 hours in fresh EM (Figure 7). All BrdU+
progenitor cells and their progeny were then counted in the three most posterior neuromasts of
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each zebrafish. Figure 8 displays the mean number of peripheral and internal supporting cells
that exhibited BrdU at the four assessment points.

A. Fewer BrdU+ Internal Supporting Cells Survive the Cisplatin Exposure than BrdU+
Peripheral Supporting Cells
During a BrdU pulse-chase experiment, BrdU+ cell counts are expected to increase gradually over time as BrdU carrying progenitors divide. In the present experiment, the reverse trend
was noted with both the BrdU+ internal and BrdU+ peripheral supporting cell counts declining
between 0 and 48 hours after cisplatin. Interestingly, the mean BrdU+ counts for the peripheral
supporting cells were significantly higher (p < 0.5 x 10-8) than those obtained for the internal
supporting cells at every time point. This is the opposite of what was observed for the cisplatintreated animals in the BrdU pulse-fix experiments.
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Figure 7. Supporting cell proliferation in the three most posterior neuromasts of zebrafish after cisplatin
treatment, a four-hour BrdU pulse (12 hours after cisplatin), and zero to three days (0D-3D) of recovery.
Cells entering S-phase are labeled with BrdU and surrounding cell nuclei are counterstained with DAPI.
A-D. Images depict representative neuromasts from cisplatin-treated (CDDP) animals in the BrdU pulse-chase
experiment. The number of BrdU+ cells gradually declines with longer survival periods, and BrdU+ internal
supporting cells are noticeably absent for survival periods longer than a day. Long arrows with pointed tails indicate
sample peripheral supporting cells, and the single short arrow indicates a sample internal supporting cell. Scale bars
= 10 micrometers (μm).
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Figure 8. Time course graph showing the mean number of internal and peripheral BrdU+ cells per neuromast at each of the 0-24 hour assessment points for the cisplatin-treated animals in the BrdU pulse-chase
experiment. Mean BrdU+ peripheral supporting cell counts are significantly higher than mean BrdU+ internal
supporting cell counts at all of the assessment points. Error bars represent positive standard deviations (N = 10-11
fish per condition, 3 neuromasts per fish). Solitary asterisks indicate a significant difference (p < 0.5 x 10-8) between
the mean internal and peripheral supporting cell counts.

III. Results for Individual Neuromasts
Previous research has shown that the number of hair cells regenerated following ototoxic
injury is not uniform across lateral line neuromasts and that the number of regenerated hair cells
is highly dependent upon the original size of the damaged neuromasts (Ma et al. 2008; Genualdi,
2012). According to Ledent (2002), lateral line neuromasts in zebrafish larvae can vary in size
depending upon whether they were developed early as part of the embryonic lateral line or later
as part of the maturing lateral line. In the present experiment, differing levels of supporting cell
proliferation were noted but not found to be significant amongst the three most posterior neuromasts in the control and experimental groups (ANOVAs, p > 0.05). Data from the BrdU pulse-
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chase experiment are provided for illustrative purposes (Figure 9). Since proliferating supporting cells have been implicated as hair cell and supporting cell progenitors (Williams and Holder,
2000; Harris et al., 2003; Ma et al., 2008; reviewed in Stone and Contanche, 2007; Oesterle and
Stone, 2008; Warchol, 2011; and Brignull et al., 2009), it is possible that these subtle differences

Mean Number of BrdU+ Cells Per Neuromast

reflect natural size variations in lateral line neuromasts as well.

Figure 9. Time course graph showing the mean number of BrdU+ cells counted in each of the three most posterior neuromasts in the BrdU pulse-chase experiment. One way ANOVAs were performed and did not reveal
significant differences amongst the three most posterior neuromasts at any of the assessment points. Error bars
represent positive standard deviations (N = 10-11 fish per condition, 3 neuromasts per fish).
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DISCUSSION

I. Initial Proliferation Levels in Controls May Be Due to Ongoing Development
Compared to control data published in other studies, the level of proliferation noted in
our control animals is mostly consistent with previous findings. Harris et al. (2003) and Ma et al.
(2008) assessed cell proliferation in the neuromasts of 4-5 dpf zebrafish larvae fixed after a 24
hour survival period, and they rarely found more than two BrdU-labeled cells per neuromast.
This number is substantially lower than the average number of BrdU+ cells we observed per
neuromast at this time point (13.95 ± 4.64 cells per neuromast) but comparable with those
observed at the 48 to 96 hour time points. It should be noted, however, that both Harris et al.
(2003) and Ma et al. (2008) used a higher concentration of BrdU (10 mM) and a shorter pulse
(one hour).
Another explanation that may account for this apparent discrepancy in control data is that
5-6 dpf larvae are still undergoing developmental growth during this period. In experiments conducted by Ma et al. (2008), five dpf controls exhibited as much as a 20% increase in FM1-43Xlabeled, myosin VI-labeled, and HCS-1-labeled hair cells during the first 48 hours following
mock treatment. Moderate levels of atoh1 and notch3 transcripts as well as low levels of deltaA
transcripts were also detected up to this point in time in controls. The authors attributed these
findings to possible hair cell addition resulting from ongoing lateral line development.

II. Increased Proliferation in Cisplatin-Treated Animals is Delayed and Prolonged
The initiation of increased supporting cell proliferation after treatment with 1000 μM cisplatin was delayed compared to that following treatment with 400-500 μM neomycin. Between
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12 and 21 hours post-neomycin exposure, a significant increase in BrdU+ supporting cells was
observed in experimental neuromasts. This increase was then downregulated to near control
levels by 24 hours post-injury (Harris et al., 2003; Ma et al., 2008). In the present study,
cisplatin-induced proliferation was not seen until 24 hours after the reported starting point for
neomycin. In addition, the time course for cisplatin-induced proliferation was approximately 24
hours longer than that observed for neomycin treatment.

III. Proliferation Patterns May Be Due to Extensive Cell Death in Cisplatin-Treated Neuromasts
The lack of localized proliferation observed in the BrdU pulse-fix and BrdU pulse-chase
experiments (BrdU pulse-chase data were not shown) suggests that hair cell loss occurs with
concomitant supporting cell loss. The reason why Ma et al. (2008) recorded higher BrdU+ counts
for the internal supporting cell population is likely due to the fact that neomycin specifically
targets hair cells and not supporting cells. If cisplatin targets both hair cells and dividing supporting cells, then equivalent proliferation levels would be expected between the internal and
peripheral supporting cell populations at some point following treatment. Internal supporting
cells would need to divide to replace lost hair cells, and peripheral supporting cells would need
to divide to replace lost inner supporting cells.
In the BrdU pulse-fix experiment, the 24 hour control animals were the only ones to
exhibit significantly more BrdU+ internal and BrdU+ dorsoventral cells. Why this was the case
is not clear. Perhaps this difference reflects a period of active neuromast growth at 5-6 dpf that is
not seen over the next 72 hours.
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IV. Many BrdU+ Internal Supporting Cells Do Not Survive Cisplatin Exposure
The purpose of the BrdU pulse-chase experiment was to keep a running tabulation of
approximately how many BrdU+ cells were produced after cisplatin treatment in the three most
posterior neuromasts. Every time a BrdU+ progenitor cell divides, the BrdU analog persists in its
daughter cells, and so BrdU+ cell counts are expected to become increasingly larger with
progressively longer periods of survival—particularly if the progeny of those progenitor cells are
induced to divide. Interestingly, BrdU+ cell counts did not continuously increase with each
added recovery period of 24 hours in the present experiment. In fact, the reverse trend was
observed between 0 and 48 hours after BrdU incubation. Since fewer BrdU+ cells were counted
than expected with the pulse-chase protocol, this suggests that many of the daughter cells
resulting from early mitotic divisions do not survive the cisplatin treatment even with extended
recovery periods. This is the opposite of what Ma et al. (2008) observed when treating lateral
line neuromasts with neomycin and indicates that cisplatin is toxic to both hair cells and
supporting cells while neomycin is not.
Another interesting finding was the change in BrdU+ counts obtained for the internal
versus peripheral supporting cell populations seen in Figures 5 and 8. In Figure 5, there were no
significant differences between the two cell populations for BrdU incorporation in the experimental animals. In Figure 8, however, the mean BrdU+ counts for the peripheral cells were significantly higher than the mean BrdU+ counts for the internal cells at all of the survival periods.
These findings suggest that internal supporting cell progenitors are far more susceptible to the
effects of ciplatin than are peripheral supporting cells. Why this may be the case is unclear, but it
is possible that peripheral supporting cells are less affected because they only begin dividing
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after some unknown threshold of internal supporting cell death. A later time point of division
may, therefore, permit peripheral cell nuclei to have less direct exposure to cisplatin.

V. Regenerative Processes within the Zebrafish Lateral Line May Be Impaired Due to
Limited Progenitor Survival
As was discussed previously, cisplatin appears to impair the hair cell regenerative processes of both the chick inner ear and the zebrafish lateral line, although the former seems to be
far less capable of overcoming the insult than the latter. In the chick inner ear, hair cell regeneration was not seen in cisplatin-treated organotypic cultures for as many as seven days post-exposure (Slattery and Warchol, 2010). Hair cell regeneration in the zebrafish lateral line, however,
was identified but found not to be complete by 10 days post-cisplatin treatment (Genualdi, 2012;
Mackenzie and Raible, 2012). While the proliferative responses of both species are different, it is
possible that both are impaired by the same underlying mechanism – cisplatin’s toxicity to hair
cells, supporting cells, and proliferating cells in general.
Results from the present study indicate that a transient increase in supporting cell proliferation is seen between 48 and 72 hours post-treatment with 1000 μM cisplatin, but many of
these putative progenitors do not appear to survive long enough to contribute to the regenerative
process in a meaningful way. This seems particularly true for BrdU+ internal supporting cells
which have been hypothesized to divide and give rise to new neuromast hair cells (Ma et al.,
2008). The reason why progenitor progeny fail to survive after treatment with cisplatin is obscure but presumably there are lingering toxic effects from the cisplatin exposure that affect the
internal supporting cell population similar to the hair cell population (Ou et al., 2007). At 96
hours post-treatment, the number of supporting cells entering S-phase in the three most posterior
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neuromasts of the zebrafish lateral line returns to control levels and hair cell replacement is still
incomplete. Based on these observations, the delayed regenerative response observed in zebrafish larvae may be related to limited internal supporting cell survival. Over time, when lingering
toxic effects from cisplatin have waned, the less susceptible peripheral supporting cells may
gradually restore the hair cell regenerative mechanism by dividing, migrating, and differentiating
into new internal supporting cells inside neuromasts (Harris et al., 2003).

FUTURE DIRECTIONS

I. Identifying the Mechanism of Internal Supporting Cell Death
Findings from the present study have suggested that internal supporting cells are more
susceptible to injury by cisplatin than are peripheral supporting cells in the zebrafish lateral line.
The method by which cisplatin effectively removes inner supporting cell progeny from zebrafish
neuromasts is not known, but the creation of intrastrand cross-links is a likely culprit given the
data collected. Since internal supporting cells undergo mitosis at an earlier time point after hair
cell death than do peripheral cells, the development of DNA adducts and the inhibition of DNA
synthesis would explain why they are comparatively more susceptible. Future research endeavors
should explore the manner in which inner supporting cells are targeted by cisplatin (i.e., DNA
cross-link formation versus upregulation of ROS) and how long this mechanism remains in
effect and delays the regeneration of lateral line hair cells. Recommended analytic tools include
adduct-specific monoclonal antibodies (used in mice in Liedert, Pluim, Schellens, and Thomale,
2006 and Dzagnidze et al., 2007) and TUNEL staining (used in zebrafish in López-Schier and
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Hudspeth, 2006) as they would permit one to assess the rate of DNA platination and supporting
cell apoptosis, respectively.

II. Comparing Results with Those Obtained in Mature Animals
Zebrafish larvae are currently a popular choice for performing hair cell regeneration studies for many of the reasons discussed previously. Larvae, however, are still in the process of
maturing. If the goal is to make hair cell regeneration therapy a viable treatment option for both
children and adults, then studies should work to identify animal models that are easy to work
with and that maintain a regenerative response in their adult form. Until recently, this was
difficult in the mature zebrafish due to its opaque constitution. The casper line developed
by White el al. (2008), however, has offered a unique opportunity. In the casper line, black
melanophores and reflective iridophores are absent from the epidermal, dermal, and hypodermal
layers of the fish. These mutations give the adult zebrafish a transparent appearance that makes it
ideal for studies utilizing immunofluorescence. In addition, the casper line does not exhibit
premature mortality compared to wild-type controls, and it maintains all of the benefits associated with wild-type larvae. Prior to comparing the regenerative response of adults versus
larvae, however, future research should address whether or not the casper line mutations have
any effect on hair cell death and regenerative processes in young larvae.
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CONCLUSION
Hair cell regeneration research in animal models is important as the knowledge gained
may contribute to the development of human hair cell replacement therapies as well as highlight
some of the limitations associated with these potential interventions. In the present study, five
dpf zebrafish larvae were treated with 1000 μM cisplatin for four hours and then a.) allowed to
recover for 24-96 hours before receiving a pulse of BrdU or b.) pulsed with BrdU 12 hours after
cisplatin treatment and then permitted to recover for 0-72 hours. Results indicate that cisplatin
induces both hair cell and supporting cell death as an increased and homogenous spread of
proliferation was noted between 24-48 hours after cisplatin in the three most posterior neuromasts of the experimental group. While supporting cell proliferation was observed to be elevated
during this time, long-term survival of internal supporting cell progeny was not. Considering that
supporting cells are the progenitors of replacement hair cells, these finding may explain why hair
cell regeneration is either absent or delayed post-cisplatin treatment. These results have
identified a clear deficit in the hair cell regenerative mechanism.
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APPENDIX

Supplemental Tables Containing Descriptive Data for the BrdU Pulse-Fix and Pulse-Chase
Experiments
Table 1. Mean Control Data from the BrdU Pulse-Fix Experiment
Survival Period Neuromast N
1 Day
2 Day
3 Day
4 Day

21
44
47
22

Peripheral SC
Singlet
Pair
Total
5.14
1.25
0.40
0.82

0.14
0.05
0.00
0.05

5.43
1.34
0.40
0.91

Singlet
7.19
1.05
0.51
0.95

Internal SC
Pair
Total
0.67
0.05
0.13
0.23

8.52
1.14
0.77
1.41

Ant/Post Dor/Vent Total SC
5.90
1.48
0.57
1.00

8.05
1.00
0.60
1.32

13.95
2.48
1.17
2.32

Table 2. Standard Deviations for Mean Control Data from the BrdU Pulse-Fix Experiment
Survival Period Neuromast N
1 Day
2 Day
3 Day
4 Day

21
44
47
22

Peripheral SC
Singlet
Pair
Total
3.29
1.33
1.01
1.59

0.48
0.21
0.00
0.21

3.85
1.41
1.01
1.93

Internal SC
Singlet
Pair
Total
2.80
1.66
0.91
1.59

0.80
0.21
0.34
0.43

2.91
1.68
1.00
1.53

Ant/Post Dor/Vent Total SC
2.91
1.70
0.83
1.23

3.11
1.22
0.83
2.01

4.64
2.30
1.22
2.83

Table 3. Mean Experimental Data from the BrdU Pulse-Fix Experiment
Survival Period Neuromast N
1 Day
2 Day
3 Day
4 Day

21
25
33
30

Peripheral SC
Singlet
Pair
Total
5.24
3.36
0.97
0.77

0.10
0.08
0.00
0.00

5.43
3.52
0.97
0.77

Singlet
6.62
1.92
1.39
1.23

Internal SC
Pair
Total
0.33
0.16
0.03
0.10

7.29
2.24
1.45
1.43

Ant/Post Dor/Vent Total SC
6.29
2.92
1.09
1.03

6.43
2.84
1.33
1.17

12.71
5.76
2.42
2.20

Table 4. Standard Deviations for Mean Experimental Data from the BrdU Pulse-Fix Experiment
Survival Period Neuromast N
1 Day
2 Day
3 Day
4 Day

21
25
33
30

Peripheral SC
Singlet
Pair
Total
2.79
2.46
1.13
1.22

0.30
0.40
0.00
0.00

2.80
2.63
1.13
1.22
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Singlet
3.79
1.68
1.06
1.22

Internal SC
Pair
Total
0.58
0.37
0.17
0.40

4.05
1.94
1.20
1.48

Ant/Post Dor/Vent Total SC
3.51
1.96
1.01
1.00

3.01
2.32
1.14
1.34

5.65
3.55
1.56
1.86
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Table 5. Mean Experimental Data from the BrdU Pulse-Chase Experiment
Survival Period Neuromast N
1 Day
2 Day
3 Day
4 Day

33
33
33
30

Peripheral SC
Singlet
Pair
Total
7.55
5.58
5.36
6.17

0.06
0.03
0.00
0.10

7.67
5.64
5.36
6.37

Singlet
2.42
0.91
0.76
1.53

Internal SC
Pair
Total
0.27
0.03
0.00
0.00

2.97
0.97
0.76
1.53

Ant/PostDor/Vent Total SC
5.30
3.42
3.39
4.27

5.33
3.18
2.73
3.63

10.64
6.61
6.12
7.90

Table 6. Standard Deviations for Mean Experimental Data from the BrdU Pulse-Chase Experiment
Survival Period Neuromast N
1 Day
2 Day
3 Day
4 Day

33
33
33
30

Peripheral SC
Singlet
Pair
Total
2.54
2.89
3.03
2.95

0.24
0.17
0.00
0.55

2.61
2.86
3.03
3.00
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Internal SC
Singlet
Pair
Total
1.41
2.26
1.00
2.29

0.45
0.17
0.00
0.00

1.53
2.26
1.00
2.29

Ant/PostDor/Vent Total SC
2.20
2.19
2.11
2.59

2.12
2.11
1.99
2.17

3.03
3.89
3.43
4.05

